X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-10-02 | PSUS | Pershing Square Usa, Ltd. | Israel Ryan | Chief Investment Officer | P - Purchase | $37.47 | +256,613 | 756,613 | +51% | +$9,615,216 | |||||
2026-10-01 | ACCV | Accelevation Holdings Corp. | Rubiera Michael | CEO | P - Purchase | $18.00 | +203,200 | 1,496,308 | +16% | +$3,657,600 | ||||||
2026-10-06 | NXH | Neighborhood Intelligence, Inc. | Lemonis Marcus | Exec COB, CEO | P - Purchase | $2.76 | +362,319 | 1,076,860 | +51% | +$1,000,000 | ||||||
2026-09-30 | VCIG | Vci Global Ltd | Hoo Voon Him | CEO, Dir, 10% | P - Purchase | $1.62 | +193,349 | 341,719 | +130% | +$313,225 | ||||||
2026-10-07 | IMMR | Immersion Corp | Singer Eric | Pres, CEO | P - Purchase | $7.14 | +41,000 | 2,230,664 | +2% | +$292,800 | ||||||
| M | 2026-10-01 | NXRT | Nexpoint Residential Trust, Inc. | McGraner Matt | See Remarks | P - Purchase | $18.65 | +10,780 | 500,275 | +2% | +$201,049 | |||||
| M | 2026-10-05 | AGMB | Agomab Therapeutics Nv | Knotnerus Tim Jasper | CEO | P - Purchase | $8.58 | +11,000 | 56,217 | +24% | +$94,380 | |||||
2026-10-06 | AGMB | Agomab Therapeutics Nv | Kemula Pierre Thadee Victor | CFO | P - Purchase | $8.59 | +10,000 | 10,000 | New | +$85,940 | ||||||
2026-10-01 | ACCV | Accelevation Holdings Corp. | Jewell Brent C | COO | P - Purchase | $18.00 | +2,500 | 304,068 | +1% | +$45,000 | ||||||
| D | 2026-10-02 | SKYH | Sky Harbour Group Corp | Gonzalez Francisco | CFO | P - Purchase | $9.25 | +3,850 | 718,538 | +1% | +$35,613 | |||||
2026-10-06 | CET | Central Securities Corp | Hill John C | CEO, Pres | P - Purchase | $56.37 | +500 | 79,007 | +1% | +$28,185 | ||||||
2026-10-02 | WVVI | Willamette Valley Vineyards Inc | Osborn Michael Jordan | CEO | P - Purchase | $1.91 | +10,000 | 30,000 | +50% | +$19,065 | ||||||
2026-10-08 | UXIN | Uxin Ltd | Dai Kun | CEO | P - Purchase | $1.13 | +11,836 | 63,602 | +23% | +$13,333 | ||||||
2026-10-05 | UXIN | Uxin Ltd | Dai Kun | CEO | P - Purchase | $1.27 | +8,683 | 39,238 | +28% | +$11,016 | ||||||
2026-10-07 | WVVI | Willamette Valley Vineyards Inc | Osborn Michael Jordan | CEO | P - Purchase | $1.93 | +5,000 | 35,000 | +17% | +$9,655 | ||||||
2026-10-08 | NRXS | Neuraxis, Inc | Henrichs Timothy Robert | CFO | P - Purchase | $4.84 | +1,937 | 9,530 | +26% | +$9,375 | ||||||
2026-10-06 | UXIN | Uxin Ltd | Dai Kun | CEO | P - Purchase | $1.24 | +7,023 | 46,261 | +18% | +$8,697 | ||||||
2026-10-02 | UXIN | Uxin Ltd | Dai Kun | CEO | P - Purchase | $1.29 | +5,672 | 30,555 | +23% | +$7,323 | ||||||
2026-10-07 | UXIN | Uxin Ltd | Dai Kun | CEO | P - Purchase | $1.21 | +5,505 | 51,766 | +12% | +$6,676 | ||||||
2026-10-05 | DLPN | Dolphin Entertainment, Inc. | O'Dowd William IV | CEO, 10% | P - Purchase | $1.08 | +4,500 | 685,783 | +1% | +$4,856 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |